NADP

NADP (Netherlands Antibiotic Development Platform) facilitates public-private collaborations to accelerate development of antibiotics and alternative therapies

[NADP @NADP_AMR]

Last week, @WHO published the 2020 annual review of the antibacterial pipelines that evaluate the antibacterial candidates in different stages of development. It addresses drug-resistant bacteria outlined in the WHO Bacterial Priority Pathogens List https://t.co/B9tYeiE6sh

[Infection & Immunity UMC Utrecht @IenI_UMCUtrecht]

We at @UMCUtrecht are extremely proud!
The Royal Netherlands Academy of Arts and Sciences (@_knaw) has elected prof dr @MarcBonten as a new member. KNAW members are leading scientists from all disciplines and are selected based on their scientific merits https://t.co/bQP3TIrMuE

[NADP @NADP_AMR]

WHO: No antibiotic in development sufficiently addresses drug resistance https://t.co/sT5javJFE8

[Infection & Immunity UMC Utrecht @IenI_UMCUtrecht]

Gut microbiota composition can be used to recognize patients at increased risk of infection with C. difficile after #antibiotics treatment, concludes a study coordinated by @hvwerkhoven from @UMCUtrecht published today in @natcoms https://t.co/q8gvPBRZ1y

@MarcBonten @COMBACTE

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

This Thursday March 4, @gardp_amr will host a free webinar to discuss how we can apply the lessons learned from #COVID-19 to tackle drug resistance and ensure access to appropriate #antibiotics. Be sure to register and share with your networks: https://t.co/OGckpqP4ji

[Infection & Immunity UMC Utrecht @IenI_UMCUtrecht]

On March 1st, the European Clinical Research Alliance for Infectious Diseases (ECRAID-base) will start activities. It aspires to become in 5 yrs a pan-European clinical research network for infectious diseases and evolve into a self-sustaining academic CRO https://t.co/O0zyzRJBxT

[NADP @NADP_AMR]

JPIAMR organizes from April 20-22, 2021 a workshop led by the UK @The_MRC, titled "Feeding the #AMR Therapeutics Pipeline". The workshop will discuss new strategies for the treatment of infection and identification of resistant microbes. For details, go to https://t.co/LejUsvTwzJ

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

We’re excited to announce the announce the activation of the first site in South Africa as part of our global phase 3 trial of zoliflodacin, a novel, first-in-class treatment for #gonorrhoea. Learn more: https://t.co/0IAFM04Kzf #StopSuperBugs #AMR

[Infection & Immunity UMC Utrecht @IenI_UMCUtrecht]

Clonal dissemination appears to be the major driver of one type of resistance of Enterococcus faecium against the antibiotic vancomycin (VRE). This was concluded by @AnitaSchurch, @Sergi_Arredondo and colleagues @UMCUtrecht in Genome Medicine https://t.co/nrw4o8sYB7

@MarcBonten

[Infection & Immunity UMC Utrecht @IenI_UMCUtrecht]

Infections with Gr- bacteria (e.g. E. coli) cause significant mortality (>2,000 deaths/year) in countries with a low #AMR pressure such as the Netherlands, wrote Tim Deelen @juliuscenter in his PhD thesis that he defended today at @UniUtrecht https://t.co/VH44ERE3jH @MarcBonten

[NADP @NADP_AMR]

We are proud! Prof. Suzan Rooijakkers @UMCUtrecht, member of the @NADP_AMR Executive Board, today received a prestigeous @ERC_Research Consolidator Grant to fight AMR, focusing on antibodies against E. coli.

[Infection & Immunity UMC Utrecht @IenI_UMCUtrecht]

Please join me in congratulating Suzan Rooijakkers, professor of microbiology @UMCUtrecht, who received today a € 2M Consolidator Grant from @ERC_Research to identify antibodies that use the immune system to fight E. coli infections https://t.co/gxCBl5NPsE @MarcBonten #ERCCoG

[NADP @NADP_AMR]

This week is Antimicrobial Resistance Awareness Week. The website of @FT now features an impressive video on #AMR and how to stop the next global health crisis https://t.co/VwZjNBxjOi

[NADP @NADP_AMR]

This wednesday starts World Antimicrobial Awareness Week. On Nov 19 (15-16 hrs.) @ncohnl and @NADP_AMR jointly organize a webinar titled ‘Silent pandemic: Antimicrobial Resistance (AMR)’. For more info and registration, go to https://t.co/T2imotTmbc

[NADP @NADP_AMR]

Interesting . . .

The not-for-profit Global Antibiotic Research and Development Partnership (@gardp_amr) organizes a live webinar on November 17 (17.00-18.00 hours CET) on the use of artificial intelligence in the development of novel #antibiotics

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

Interested in Artificial Intelligence? Find out how it can be used to discover new antibiotics and prevent #AMR. Register for the webinar here: https://t.co/ckPeyd1N4W

[NADP @NADP_AMR]

We congratulate @NADP_AMR executive board member Cornelis Boersma with his appointment as extraordinary professor of Sustainable Care and Innovation at Open University. https://t.co/DvliYIR02p @OU_Nederland @ncohnl

[onehealth @ncohnl]

29 OCT 2020: FIRST VIRTUAL NCOH ASM. Do we need a new scientific approach to prevent diseases or a new pandemic? Hosted by @MarionKoopmans and @HeimanW with @ErasmusMC @RadboudUMC @RIVM @WUR @VUamsterdam. Register now! https://t.co/dB3wNSMEbs

#NCOH #COVID_19 #OneHealth

[Infection & Immunity UMC Utrecht @IenI_UMCUtrecht]

WORK!

Postdoctoral researcher microbial bioinformatics and infectious diseases. https://t.co/nASBeIJxKJ

[Access to Medicine Foundation @AtMIndex]

5.7 million people die every year from treatable bacterial diseases due to the lack of access to #antibiotics; another 700,000 die from #antimicrobialresistance. What is #pharma doing about it? See the methodology for our 2021 #AMR Benchmark, now online: https://t.co/PHZkZK4vit

[Access to Medicine Foundation @AtMIndex]

NEW: The rise of #AMR poses threats to modern medicine & our way of living. The methodology for the 2021 AMR Benchmark enables the tracking of #pharma's progress against #superbugs & a deeper exploration of the headwinds faced by biotechs driving novel R&D https://t.co/PHZkZK4vit